| 常用名 | Tepoditamab | CAS号 | 2044679-53-8 |
|---|---|---|---|
| 价格 | ¥需询单/100ug ¥需询单/500ug | 纯度 | 95.0% |
| 备货期 | 需询单 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: Tepoditamab (MCLA-117) is a bispecific monoclonal antibody that binds to CLEC12A of myeloid cells and CD3 of cytotoxic T cells. Among others, CLEC12A is a myeloid differentiation antigen. Tepoditamab (MCLA-117) kills AML leukaemia mother cells and AML leukaemia stem cells, induces T cell-mediated proliferative lysis of AML cells and can be used in acute myeloid leukaemia (AML) research[1]. 物理化学性质: CAS号:2044679-53-8 常用中文名:Tepoditamab 常用英文名:Tepoditamab 分子式: 分子量: 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A |